Stephen Songer

Suggest Changes
  • Citations Per Year
Learn More
STUDY OBJECTIVE To assess the dose proportionality of azacitidine pharmacokinetics (PK) after single subcutaneous (SC) doses of 25-100 mg/m2, and determine the effect of renal impairment on PK after(More)
BACKGROUND Azacitidine safety and efficacy were established in studies of mainly Caucasian patients. Differences in drug metabolism enzymes between Caucasian and East Asian populations prevent(More)
  • 1